Business Daily Media

Business Marketing

.

Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tazemetostat for EZH2 Gene Mutation-Positive Follicular Lymphoma

  • Written by ACN Newswire - Press Releases

Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tazemetostat for EZH2 Gene Mutation-Positive Follicular Lymphoma

TOKYO, Jul 8, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has submitted a marketing authorization application in Japan for the EZH2 inhibitor tazemetostat hydrobromide (generic name, development code: E7438, "tazemetostat") for EZH2 gene mutation-positive follicular lymphoma.

This application is based on the results of a

Read more //?#

Popular

The Ultimate Guide to the Top Household Disinfectant Products

Did you know that the oldest reference for chemical disinfection dates back to 800 BC? According to researchers, this reference is in the sixth book of Homer's Odyssey.  In hospital settings, some say that the first use of ...

Demand for Australian natural and organic products surge during COVID

According to Dr Mathew McDougall, demand for Australian natural and organic products has surged during COVID to the point where producers and manufactures are urgently ramping up capacity. Dr Mathew McDougall is the founder ...

Zeller doubles addressable market and takes on the big four with new financial services offering

Hitting a 30,000 customer milestone, Zeller launches a new transaction account, debit card and app, enabling any type of business to replace their outdated bank with Zeller.   Zeller, one of Australia’s fastest-growing compa...